Bausch Health Companies Inc., commonly referred to as Bausch Health, is a prominent global healthcare company headquartered in Canada. Founded in 2013, the company has rapidly established itself in the pharmaceutical and medical device industries, focusing on eye health, gastrointestinal health, and dermatology. With a diverse portfolio of innovative products, Bausch Health is renowned for its commitment to improving patient outcomes through advanced therapies and technologies. Key offerings include prescription medications, over-the-counter products, and surgical devices, all designed to address critical health needs. Bausch Health has achieved significant milestones, including strategic acquisitions that have bolstered its market position. The company continues to be a leader in the healthcare sector, dedicated to enhancing the quality of life for patients worldwide.
How does Bausch Health Cos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bausch Health Cos's score of 39 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Bausch Health Cos reported total greenhouse gas emissions of approximately 65,518,000 kg CO2e from Scope 2, 49,906,000 kg CO2e from Scope 1, and 38,011,000 kg CO2e from Scope 3 emissions, which includes categories such as capital goods and purchased goods and services. This reflects a commitment to transparency in their carbon footprint across all scopes of emissions. Bausch Health has set ambitious targets to reduce its greenhouse gas emissions. The company aims to achieve a 42% reduction in both Scope 1 and Scope 2 emissions by 2030, using 2020 as the baseline year. Additionally, they are committed to measuring and reducing their Scope 3 emissions, which encompass indirect emissions from their value chain. The company's emissions data shows a decrease in Scope 1 emissions from approximately 54,718,000 kg CO2e in 2016 to about 49,906,000 kg CO2e in 2023, indicating progress towards their reduction goals. Bausch Health's initiatives align with industry standards for climate action, demonstrating their commitment to sustainability and responsible environmental stewardship.
Access structured emissions data, company-specific emission factors, and source documents
2016 | 2018 | 2019 | 2022 | 2023 | |
---|---|---|---|---|---|
Scope 1 | 547,180,000 | 000,000,000 | - | 00,000,000 | 00,000,000 |
Scope 2 | - | - | - | 00,000,000 | 00,000,000 |
Scope 3 | - | - | 000,000 | 00,000,000 | 00,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bausch Health Cos is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.